Aurinia Pharmaceuticals Inc (AUPH) insider trading
Every open-market stock purchase and sale by Aurinia Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Stephen P. Robertson (C-suite exec) sold $546K in the last 90 days.
- Last insider buy: Kevin Tang (CEO), $3.1M, 4 months ago.
Last 12 months: insiders bought $25.1M (2 buys) and sold $546K (2 sales). Last close $16.10 on Sep 11, 2026.
Recent AUPH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 10, 2026 | Stephen P. Robertson (C-suite exec) | Sold | $190K |
| Aug 21, 2026 | Stephen P. Robertson (C-suite exec) | Sold | $356K |
| Jun 4, 2026 | Tina Susan Nova (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Kathleen Goetz (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Jeffrey Allen Bailey (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Craig A Johnson (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Kevin Tang (CEO) | Bought | $3.1M |
| Jun 2, 2026 | Kevin Tang (CEO) | Bought (not open market) | $16.5K |
| Jun 1, 2026 | Kevin Tang (CEO) | Bought | $5.2M |
| Jun 1, 2026 | Kevin Tang (CEO) | Bought | $1.5K |
| May 29, 2026 | Kevin Tang (CEO) | Bought | $4M |
| May 29, 2026 | Kevin Tang (CEO) | Bought | $35.3K |
| May 18, 2026 | Ryan Cole (COO) | Bought (not open market) | — |
| May 18, 2026 | Ryan Cole (COO) | Bought (not open market) | — |
| May 18, 2026 | Michael S Hearne (CFO) | Bought (not open market) | — |
| May 18, 2026 | Stephen P. Robertson (C-suite exec) | Bought (not open market) | — |
| May 18, 2026 | Michael S Hearne (CFO) | Bought (not open market) | — |
| Mar 6, 2026 | Greg Keenan (C-suite exec) | Sold (not open market) | $116K |
| Mar 3, 2026 | Kevin Tang (Insider) | Bought | $2.6M |
| Mar 2, 2026 | Kevin Tang (Insider) | Bought | $1.6M |
| Mar 2, 2026 | Peter Greenleaf (CEO) | Sold (not open market) | $1.4M |
| Mar 2, 2026 | Kevin Tang (Insider) | Bought | $1.2M |
| Mar 2, 2026 | Matthew Maxwell Donley (COO) | Sold (not open market) | $579K |
| Mar 2, 2026 | Joseph M Miller (CFO) | Sold (not open market) | $533K |
| Mar 2, 2026 | Stephen P. Robertson (VP) | Sold (not open market) | $519K |
Who's trading AUPH
- Stephen P. Robertson, VP: sold $546K (2 sales), last Sep 10, 2026
- Jeffrey Allen Bailey, Director: other filings, last Jun 4, 2026
- Kathleen Goetz, Director: other filings, last Jun 4, 2026
- Craig A Johnson, Director: other filings, last Jun 4, 2026
- Tina Susan Nova, Director: other filings, last Jun 4, 2026
- Kevin Tang, Insider: bought $25.1M (11 buys), last Jun 2, 2026
- Ryan Cole, COO: other filings, last May 18, 2026
- Michael S Hearne, CFO: other filings, last May 18, 2026
- Greg Keenan, C-suite exec: other filings, last Mar 6, 2026
- Joseph M Miller, CFO: other filings, last Mar 2, 2026
- Matthew Maxwell Donley, COO: other filings, last Mar 2, 2026
- Peter Greenleaf, CEO: other filings, last Mar 2, 2026
Get free alerts when an insider at Aurinia Pharmaceuticals Inc files a new trade →